Adult HGBCL, NOS, cases had lower expression of IRF3, KRAS, and NF‐κB‐related signatures, and lower expression of stromal, myeloid, macrophage, and monocyte signatures when compared with de novo ABC‐DLBCL (Figure 5B). The gene discussed is NFKB1; the disease is diffuse large B-cell lymphoma.